X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES GSK PHARMA ALKEM LABORATORIES/
GSK PHARMA
 
P/E (TTM) x - 67.4 - View Chart
P/BV x 6.7 11.8 56.4% View Chart
Dividend Yield % 0.7 1.1 60.7%  

Financials

 ALKEM LABORATORIES   GSK PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
GSK PHARMA
Mar-17
ALKEM LABORATORIES/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,5893,838 41.4%   
Low Rs1,2322,637 46.7%   
Sales per share (Unadj.) Rs417.5354.2 117.9%  
Earnings per share (Unadj.) Rs56.339.8 141.6%  
Cash flow per share (Unadj.) Rs64.742.9 150.9%  
Dividends per share (Unadj.) Rs12.7030.00 42.3%  
Dividend yield (eoy) %0.90.9 97.2%  
Book value per share (Unadj.) Rs292.9236.9 123.6%  
Shares outstanding (eoy) m119.5784.70 141.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.49.1 37.0%   
Avg P/E ratio x25.181.4 30.8%  
P/CF ratio (eoy) x21.875.5 28.9%  
Price / Book Value ratio x4.813.7 35.2%  
Dividend payout %22.675.4 29.9%   
Avg Mkt Cap Rs m168,653274,216 61.5%   
No. of employees `000NA4.7 0.0%   
Total wages/salary Rs m9,1714,830 189.9%   
Avg. sales/employee Rs ThNM6,387.0-  
Avg. wages/employee Rs ThNM1,028.3-  
Avg. net profit/employee Rs ThNM717.1-  
INCOME DATA
Net Sales Rs m49,91530,000 166.4%  
Other income Rs m1,645728 225.9%   
Total revenues Rs m51,56130,728 167.8%   
Gross profit Rs m8,4824,190 202.5%  
Depreciation Rs m1,006263 382.4%   
Interest Rs m6710-   
Profit before tax Rs m8,4514,655 181.5%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m1,6061,744 92.1%   
Profit after tax Rs m6,7313,368 199.9%  
Gross profit margin %17.014.0 121.7%  
Effective tax rate %19.037.5 50.7%   
Net profit margin %13.511.2 120.1%  
BALANCE SHEET DATA
Current assets Rs m27,06216,742 161.6%   
Current liabilities Rs m15,3247,202 212.8%   
Net working cap to sales %23.531.8 73.9%  
Current ratio x1.82.3 76.0%  
Inventory Days Days6752 128.4%  
Debtors Days Days4121 198.6%  
Net fixed assets Rs m12,6108,635 146.0%   
Share capital Rs m239847 28.2%   
"Free" reserves Rs m34,49019,222 179.4%   
Net worth Rs m35,02720,069 174.5%   
Long term debt Rs m1,21210 12,116.0%   
Total assets Rs m54,38730,038 181.1%  
Interest coverage x13.6NM-  
Debt to equity ratio x00 6,941.9%  
Sales to assets ratio x0.91.0 91.9%   
Return on assets %13.611.2 121.4%  
Return on equity %19.216.8 114.5%  
Return on capital %24.925.5 97.6%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,563528 1,243.0%   
Fx outflow Rs m3,0127,193 41.9%   
Net fx Rs m3,552-6,665 -53.3%   
CASH FLOW
From Operations Rs m7,2592,360 307.6%  
From Investments Rs m1,8643,008 62.0%  
From Financial Activity Rs m-9,273-5,108 181.5%  
Net Cashflow Rs m-150260 -57.6%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 33.1 10.2 324.5%  
FIIs % 0.0 23.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 15.4 -  
Shareholders   68,381 102,036 67.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ASTRAZENECA PHARMA  PANACEA BIOTECH  CADILA HEALTHCARE  NOVARTIS  PLETHICO PHARMA  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

GSK PHARMA Announces Quarterly Results (4QFY18); Net Profit Down 6.4%

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 6.4% YoY). Sales on the other hand came in at Rs 7 bn (down 4.5% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jun 22, 2018 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS